StockData
Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd. (DRTS) stock

DRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as DRTSW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 9, 2026Score 4/30
$13.38+0.02 (+0.15%)

Close on Nov 13, 2026Market cap $1.18BP/E –Yield –

Earnings

Alpha Tau Medical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2022
–
EPS, Q2 FY2022
-$0.03
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Alpha Tau Medical's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2022ended Jun 30, 2022Aug 25, 2022during market hours––-$0.03Release
Q4 FY2021ended Dec 31, 2021Mar 28, 2022before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Alpha Tau Medical has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Alpha Tau Medical puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Alpha Tau Medical filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?